Skip to main content
. Author manuscript; available in PMC: 2013 Sep 27.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2011 May 20;20(7):1368–1378. doi: 10.1158/1055-9965.EPI-11-0027

Table 2.

Invasive colorectal cancer outcome: addition of groupings of potential confounding variables

White African–American
HR (95% CI)
Hispanic
HR (95% CI)
Native American
HR (95% CI)
Asian/Pacific Islander
HR (95% CI)
Wald χ P-valuea
Model 1b 1.0 (ref) 1.16 (0.99, 1.34) 0.73 (0.54, 0.97) 0.99 (0.49, 1.98) 0.81 (0.59, 1.09) 11.07 0.03
Model 1 + education (≥HS vs. <HS) 1.0 (ref) 1.17 (1.01, 1.36) 0.76 (0.57, 1.02) 1.01 (0.50, 2.03) 0.79 (0.58, 1.08) 10.64 0.03
Model 1 + history of diabetes 1.0 (ref) 1.12 (0.96, 1.30) 0.71 (0.54, 0.95) 0.95 (0.47, 1.90) 0.80 (0.59, 1.08) 10.13 0.04
Model 1 + lifestyle factors (BMI, physical
 activity, smoking, alcohol)
1.0 (ref) 1.09 (0.92, 1.28) 0.75 (0.55, 1.01) 0.93 (0.44, 1.95) 0.92 (0.67, 1.25) 5.26 0.26
Model 1 + NSAID use/duration 1.0 (ref) 1.15 (0.99, 1.34) 0.72 (0.54, 0.96) 0.99 (0.49, 1.99) 0.84 (0.61, 1.15) 11.14 0.03
Model 1 + dietary factors (total energy,
 fiber, red meat, fruits and vegetables)
1.0 (ref) 1.11 (0.94, 1.29) 0.73 (0.54, 0.98) 1.03 (0.51, 2.06) 0.79 (0.57, 1.09) 8.49 0.08
Model 1 + total calcium intake 1.0 (ref) 1.08 (0.92, 1.26) 0.71 (0.53, 0.96) 1.02 (0.51, 2.05) 0.77 (0.56, 1.06) 8.93 0.06
Model 1 + screening, polyp removal and family history 1.0 (ref) 1.19 (1.01, 1.40) 0.70 (0.51, 0.96) 1.05 (0.50, 2.20) 0.83 (0.61, 1.14) 11.32 0.02
Model 1 + hormone therapy use 1.0 (ref) 1.09 (0.93, 1.26) 0.71 (0.53, 0.94) 0.98 (0.49, 1.96) 0.81 (0.60, 1.11) 8.97 0.06
a

From a Wald χ2 4 degrees of freedom test of the main effect of race/ethnicity

b

Adjusted for age, and stratified on WHI trial and extension study participation.